Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.51 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.46 |
| ▸ | DRD2 | P14416 | 5/20 | 0.44 |
| ▸ | DRD3 | P35462 | 5/20 | 0.44 |
| ▸ | DRD4 | P21917 | 2/20 | 0.44 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9392973 | 0.93 | HRH4 (0.49) | HRH4HRH3DRD2DRD3DRD4 | |
| Oxalic Acid SCHEMBL8683797 | 0.88 | HRH4 (0.45) | HRH4HRH3DRD2DRD3DRD4 | |
| SCHEMBL8874246 | 0.84 | KDR (0.45) | HRH4DRD2DRD3DRD4 | |
| SCHEMBL8683088 | 0.80 | DRD4 (0.60) | HRH4HRH3DRD2DRD3DRD4 | |
| SCHEMBL8984029 | 0.79 | SIGMAR1 (0.50) | DRD2DRD3DRD4 | |
| SCHEMBL1388460 | 0.78 | DRD4 (0.67) | DRD2DRD3DRD4 | |
| SCHEMBL8681808 | 0.76 | HRH4 (0.73) | HRH4HRH3DRD2DRD3DRD4 | |
| SCHEMBL9396195 | 0.76 | HRH4 (0.54) | HRH4HRH3DRD2DRD3DRD4 | |
| SCHEMBL9091956 | 0.74 | BCHE (0.57) | DRD2DRD3DRD4 | |
| SCHEMBL8873570 | 0.74 | KDR (0.45) | DRD2DRD3DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1994024105-A1 | INDOLE DERIVATIVES AS DOPAMINE D4 ANTAGONISTS | MERCK SHARP & DOHME LIMITED (GB) | 1994-10-27 | — | — | WO | claimed |
| WO-1994024105-A1 | INDOLE DERIVATIVES AS DOPAMINE D4 ANTAGONISTS | MERCK SHARP & DOHME LIMITED (GB) | 1994-10-27 | — | — | WO | disclosed |